Mr. Aygun joined Ponder & Co. in 2004. As a Director for the M&A Group, he is responsible for evaluating the financial performance of hospitals and healthcare systems, market analysis and valuation. Mr. Aygun also focuses on strategic options assessments and assists in transaction development and execution processes.
Previously, Mr. Aygun worked in Ponder & Co.’s Capital Markets Group where he was primarily responsible for the quantitative analysis of structuring and pricing of debt and derivative products. During his tenure with the firm, he has advised on more than 450 transactions totaling $40 billion in notional amount. Utilizing Ponder’s proprietary model, Mr. Aygun was able to precisely value interest rate swaps and provide clients assistance with FASB reporting requirements. In addition, he prepared capital structure assessment reports covering risk assessment, cash flow expectations, mark-to-market sensitivity, interest rate sensitivity and statistical analysis.
Mr. Aygun holds a B.S. in economics and finance from Vanderbilt University in Nashville, Tennessee, and was honored with Cum Laude distinction.